Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  IQVIA Holdings Inc.    IQV

IQVIA HOLDINGS INC.

(IQV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/18/2021 02/19/2021 02/22/2021 02/23/2021 02/24/2021 Date
187.71(c) 188.7(c) 190.14(c) 191.05(c) 194.59(c) Last
713 227 788 636 788 068 1 262 176 1 350 345 Volume
-0.65% +0.53% +0.76% +0.48% +1.85% Change
More quotes
Financials (USD)
Sales 2021 12 793 M - -
Net income 2021 713 M - -
Net Debt 2021 10 353 M - -
P/E ratio 2021 52,4x
Yield 2021 -
Sales 2022 13 884 M - -
Net income 2022 904 M - -
Net Debt 2022 9 910 M - -
P/E ratio 2022 40,4x
Yield 2022 -
Capitalization 37 221 M 37 221 M -
EV / Sales 2021 3,72x
EV / Sales 2022 3,39x
Nbr of Employees 70 000
Free-Float 74,3%
More Financials
Company
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions,... 
Sector
Biotechnology & Medical Research
Calendar
04/13 | 09:00am
More about the company
Notations Surperformance© of IQVIA Holdings Inc.
Trading Rating : Investor Rating :
More Ratings
All news about IQVIA HOLDINGS INC.
02/17IQVIA : Prices Sale of $1.75 Billion in Combined Senior Notes Due 2026, 2029
MT
02/17IQVIA : Announces Pricing of Offering of Senior Notes
BU
02/16IQVIA HOLDINGS INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/16IQVIA : Subsidiary to Raise EUR1.45 Billion Through Senior Notes Offering
MT
02/16IQVIA : Announces Offering of Senior Notes
BU
02/16PRESS RELEASE : Basilea reports strong 2020 -3-
DJ
02/11IQVIA : Baird Adjusts Price Target on IQVIA Holdings to $221 From $208, Keeps Ou..
MT
02/11IQVIA : Mizuho Adjusts Price Target on IQVIA Holdings to $210 From $200, Reitera..
MT
02/11IQVIA : Mizuho Adjusts Price Target on IQVIA Holdings to $210 From $200, Maintai..
MT
02/11IQVIA : Truist Adjusts Price Target on IQVIA Holdings to $235 From $197, Reitera..
MT
02/11IQVIA : Wells Fargo Adjusts Price Target on IQVIA Holdings to $230 From $205, Re..
MT
02/11IQVIA : Piper Sandler Adjusts Price Target on IQVIA Holdings to $204 From $179, ..
MT
02/11IQVIA : Morgan Stanley Adjusts IQVIA Holdings' Price Target to $220 From $205, M..
MT
02/11IQVIA : UBS Adjusts Price Target on IQVIA Holdings to $235 From $224, Keeps Buy ..
MT
02/11IQVIA : 's Orchestrated Customer Engagement (OCE) Solution Selected by 140 Life ..
BU
More news
News in other languages on IQVIA HOLDINGS INC.
02/23GENFIT : une étude souligne le potentiel d'elafibranor
02/23GENFIT : dans la PBC, elafibranor a du potentiel
02/17KOLINPHARMA : prosegue in 4* trim crescita prescrizioni mediche
02/16BASILEA PHARMACEUTICA : GlobeNewswire/Basilea meldet für 2020 starke -3-
2020Corona-Krise wirbelt den Apothekenmarkt weiter durcheinander
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Average target price 218,00 $
Last Close Price 194,59 $
Spread / Highest target 22,3%
Spread / Average Target 12,0%
Spread / Lowest Target -19,3%
EPS Revisions
Managers and Directors
NameTitle
Ari Bousbib Chairman, President & Chief Executive Officer
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
James Grant Berkshire Senior Vice President-Business Operations
John M. Leonard Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IQVIA HOLDINGS INC.8.61%37 221
MODERNA, INC.38.59%57 295
LONZA GROUP AG4.15%48 455
CELLTRION, INC.-21.45%34 686
SEAGEN INC.-11.49%28 084
HANGZHOU TIGERMED CONSULTING CO.,LTD-5.39%20 223